MR enterographic manifestations of small bowel crohn disease

Radiographics

Volumn 30, Issue 2, 2010, Pages 367-384

  Tolan, Damian J M ^a   Greenhalgh, Rebecca ^b   Zealley, Ian A ^c   Halligan, Steve ^d   Taylor, Stuart A ^d  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROHN DISEASE; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SMALL INTESTINE;

CROHN DISEASE; HUMANS; IMAGE ENHANCEMENT; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING;

EID: 77950116998     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.302095028     Document Type: Article

References (50)

1. Jaffe TA, Gaca AM, Delaney S, et al. Radiation doses from small-bowel follow-through and abdominopelvic MDCT in Crohn's disease. AJR Am J Roentgenol 2007;189(5):1015-1022.
2. Maglinte DD, Sandrasegaran K, Lappas JC, Chiorean MC. CT enteroclysis. Radiology 2007;245(3): 661-671.
3. Raptopoulos V, Schwartz RK, McNicholas MM, Movson J, Pearlman J, Joffe N. Multiplanar helical CT enterography in patients with Crohn's disease. AJR Am J Roentgenol 1997;169(6):1545-1550.
4. Bodily KD, Fletcher JG, Solem CA, et al. Crohn disease: mural attenuation and thickness at contrastenhanced CT enterography-correlation with endoscopic and histologic findings of inflammation. Radiology 2006;238(2):505-516.
5. Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology 2006; 241(3):787-795.
6. Hara AK, Alam S, Heigh RI, Gurudu SR, Hentz JG, Leighton JA. Using CT enterography to monitor Crohn's disease activity: a preliminary study. AJR Am J Roentgenol 2008;190(6):1512-1516.
7. Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, smallbowel follow-through, and ileoscopy. Radiology 2006; 238 (1): 128-134.
8. Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M, Maris T, Gourtsoyiannis N. MR enteroclysis imaging of Crohn disease. RadioGraphics 2001;21(Spec Issue):S161-S172.
9. Wiarda BM, Kuipers EJ, Heitbrink MA, van Oijen A, Stoker J. MR enteroclysis of inflammatory smallbowel diseases. AJR Am J Roentgenol 2006;187(2): 522-531.
10. Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol 2008;18(3):438-447.
11. Negaard A, Sandvik L, Berstad AE, et al. MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn's disease: randomized comparison of patient acceptance. Scand J Gastroenterol 2008; 43(1):44-51.
12. Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 2007;8(4):171-178.
13. Fedorak RN, Thompson ABR. Inflammatory bowel disease. In: Thompson ABR, Shaffer EA, eds. First principles of gastroenterology. Toronto, Canada: AstraZeneca Canada, 2008.
14. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008;247(1):64-79.
15. Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55(suppl 1):i1-i15.
16. Travis SP, Stange EF, Lémann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55(suppl 1):i16-i35.
17. Florie J, Wasser MN, Arts-Cieslik K, Akkerman EM, Siersema PD, Stoker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR Am J Roentgenol 2006;186(5):1384-1392.
18. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001;177(6):1325-1332.
19. Laghi A, Paolantonio P, Passariello R. Small bowel. Magn Reson Imaging Clin N Am 2005;13(2): 331-348.
20. Buhmann-Kirchhoff S, Lang R, Kirchhoff C, et al. Functional cine MR imaging for the detection and mapping of intraabdominal adhesions: method and surgical correlation. Eur Radiol 2008;18(6): 1215-1223.
21. Laghi A, Paolantonio P, Catalano C, et al. MR imaging of the small bowel using polyethylene glycol solution as an oral contrast agent in adults and children with celiac disease: preliminary observations. AJR Am J Roentgenol 2003;180(1):191-194.
22. Paolantonio P, Tomei E, Rengo M, Ferrari R, Lucchesi P, Laghi A. Adult celiac disease: MRI findings. Abdom Imaging 2007;32(4):433-440.
23. Lohan DG, Alhajeri AN, Cronin CG, Roche CJ, Murphy JM. MR enterography of small-bowel lymphoma: potential for suggestion of histologic subtype and the presence of underlying celiac disease. AJR Am J Roentgenol 2008;190(2):287-293.
24. Jaffe TA, Miller CM, Merkle EM. Practice patterns in imaging of the pregnant patient with abdominal pain: a survey of academic centers. AJR Am J Roentgenol 2007;189(5):1128-1134.
25. McKenna DA, Meehan CP, Alhajeri AN, Regan MC, O'Keeffe DP. The use of MRI to demonstrate small bowel obstruction during pregnancy. Br J Radiol 2007;80(949):e11-e14.
26. Holzknecht N, Helmberger T, von Ritter C, Gauger J, Faber S, Reiser M. MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis with oral iron particles [in German]. Radiologe 1998;38(1):29-36.
27. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006;238(2):517-530.
28. Arrivé L, Coudray C, Azizi L, et al. Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography [in French]. J Radiol 2007;88(11 pt 1):1689-1694.
29. Kuehle CA, Ajaj W, Ladd SC, Massing S, Barkhausen J, Lauenstein TC. Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distention. AJR Am J Roentgenol 2006;187(4):W375-W385.
30. Laghi A, Carbone I, Catalano C, et al. Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR Am J Roentgenol 2001;177(6):1333-1334.
31. Ajaj W, Goyen M, Schneemann H, et al. Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention. Eur Radiol 2005;15(7):1400-1406.
32. Borthne AS, Abdelnoor M, Storaas T, Pierre-Jerome C, Kløw NE. Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging. Eur Radiol 2006;16(6):1331-1336.
33. La Brooy SJ, Avgerinos A, Fendick CL, Williams CB, Misiewicz JJ. Potentially explosive colonic concentrations of hydrogen after bowel preparation with mannitol. Lancet 1981;1(8221):634-636.
34. Kinner S, Kuehle CA, Herbig S, et al. MRI of the small bowel: can sufficient bowel distension be achieved with small volumes of oral contrast? Eur Radiol 2008;18(11):2542-2548.
35. Lohan D, Cronin C, Meehan C, Alhajeri AN, Roche C, Murphy J. MR small bowel enterography: optimization of imaging timing. Clin Radiol 2007;62(8): 804-807.
36. Cronin CG, Lohan DG, Mhuircheartaigh JN, et al. MRI small-bowel follow-through: prone versus supine patient positioning for best small-bowel distention and lesion detection. AJR Am J Roentgenol 2008;191(2):502-506.
37. Meyers MA, McGuire PV. Spiral CT demonstration of hypervascularity in Crohn disease: "vascular jejunization of the ileum" or the "comb sign." Abdom Imaging 1995;20(4):327-332.
38. Dyde R, Chapman AH, Gale R, Mackintosh A, Tolan DJ. Precautions to be taken by radiologists and radiographers when prescribing hyoscine-Nbutylbromide. Clin Radiol 2008;63(7):739-743.
39. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70(3):439-444.
40. Sempere GA, Martinez Sanjuan V, Medina Chulia E, et al. MRI evaluation of inflammatory activity in Crohn's disease. AJR Am J Roentgenol 2005;184(6): 1829-1835.
41. Dossett LA, White LM, Welch DC, et al. Small bowel adenocarcinoma complicating Crohn's disease: case series and review of the literature. Am Surg 2007;73(11):1181-1187.
42. Masselli G, Brizi GM, Parrella A, Minordi LM, Vecchioli A, Marano P. Crohn disease: magnetic resonance enteroclysis. Abdom Imaging 2004;29(3): 326-334.
43. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 2009;252(3):712-720.
44. Harisinghani MG, Wittenberg J, Lee W, Chen S, Gutierrez AL, Mueller PR. Bowel wall fat halo sign in patients without intestinal disease. AJR Am J Roentgenol 2003;181(3):781-784.
45. Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessment of active bowel segments in Crohn's disease. Clin Radiol 2002;57(10):913-918.
46. Jain S, Koirala J, Castro-Pavia F. Isolated gastrointestinal histoplasmosis: case report and review of the literature. South Med J 2004;97(2):172-174.
47. Alterman DD, Cho KC. Histoplasmosis involving the omentum in an AIDS patient: CT demonstration. J Comput Assist Tomogr 1988;12(4):664-665.
48. Rieber A, Aschoff A, Nüssle K, et al. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 2000;10(9):1377-1382.
49. Cummings JR, Keshav S, Travis SP. Medical management of Crohn's disease. BMJ 2008;336(7652): 1062-1066.
50. Schreyer AG, Rath HC, Kikinis R, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut 2005; 54(2):250-256.